Abstract
Four preterm newborn infants with severe multisystem Coxsackie virus B infection were treated with an oral suspension of pleconaril (5 mg/kg per day). The patients had myocarditis, fulminant hepatitis, meningoencephalitis and disseminated intravascular coagulopathy. All four infants recovered, and no adverse effects of the treatment were noted. Conclusion: pleconaril needs to be comprehensively evaluated in this population.
Original language | English |
---|---|
Pages (from-to) | 491-493 |
Number of pages | 3 |
Journal | European Journal of Pediatrics |
Volume | 161 |
Issue number | 9 |
DOIs | |
State | Published - 2002 |
Externally published | Yes |
Keywords
- Coxsackie virus
- Enterovirus
- Neonate
- Pleconaril